Outcomes of Tricuspid Valve Prostheses After Heart Transplantation: a Systematic Review

Overview

Journal Heart Fail Rev

Date 2023 Oct 18

PMID 37851119

Authors

Besart Cuko

Massimo Baudo

Olivier Busuttil

Saud Taymoor

Karine Nubret

Stephane Lafitte

Antoine Beurton

Alexandre Ouattara

Carlo De Vincentiis

Thomas Modine

Louis Labrousse

Mathieu Pernot

Affiliations

Soon will be listed here.

Abstract

Tricuspid regurgitation (TR) is the most common valvular pathology after heart transplantation (HTx) and endomyocardial biopsy (EMB) remains responsible for the majority of cases due to the high probability of structural valve damage. The aim of the present review was to describe the results of surgical management of severe tricuspid regurgitation through tricuspid valve replacement (TVR) after a previous HTx. A systematic review was conducted by searching Pubmed, ScienceDirect, SciELO, DOAJ, and Cochrane databases until June 2023 for publications reporting patients undergoing TVR surgery after a previous HTx. If no right heart valve surgery was undertaken, or a heterotopic heart transplant was performed, or if the concomitant procedure was performed during the transplant itself, the paper was excluded. Twenty articles met our inclusion criteria out of 1532 potentially eligible studies, with a total of 300 patients. Mean age was 55.1 ± 9.6 years, and 85.1% were male. The mean number of EMB per patient was 31.1 ± 5.5 with a mean time between HTx and TVR of 7.64 ± 3.31 years. Bioprostheses were used in 83.3% of cases and 75.0% of patients with a bioprosthesis were reported as alive at last follow-up. Tricuspid valve repair is a valuable option, but these patients will be susceptible to recurrent TR after EMB. TVR with a bioprosthesis may provide the optimal solution for this subset of patients, as EMB is not feasible with a mechanical valve.

References

Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M . 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18):e895-e1032. DOI: 10.1161/CIR.0000000000001063. View

Lopez-Vilella R, Paniagua-Martin M, Gonzalez-Vilchez F, Donoso Trenado V, Barge-Caballero E, Sanchez-Lazaro I . Prevalence of Tricuspid Regurgitation After Orthotopic Heart Transplantation and Its Evolution in the Follow-up Period: A Long-Term Study. Transplant Proc. 2022; 54(9):2486-2489. DOI: 10.1016/j.transproceed.2022.09.009. View

Badiwala M, Rao V . Tricuspid valve replacement after cardiac transplantation. Curr Opin Cardiol. 2007; 22(2):123-7. DOI: 10.1097/HCO.0b013e3280125472. View

Raghavan R, Cecere R, Cantarovich M, Giannetti N . Tricuspid valve replacement after cardiac transplantation. Clin Transplant. 2006; 20(6):673-6. DOI: 10.1111/j.1399-0012.2006.00533.x. View

Goerler H, Simon A, Warnecke G, Meyer A, Kuehn C, Haverich A . Cardiac surgery late after heart transplantation: a safe and effective treatment option. J Thorac Cardiovasc Surg. 2010; 140(2):433-9. DOI: 10.1016/j.jtcvs.2010.02.033. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Coskun K, Coskun S, El Arousy M, Amin Parsa M, Schulz U, Deyerling W . Cardiac surgery after heart transplantation: coronary artery bypass grafting and heart valve replacement. Heart Surg Forum. 2007; 10(2):E110-4. DOI: 10.1532/HSF98.20061162. View

Goekler J, Zuckermann A, Osorio E, Brkic F, Uyanik-Uenal K, Laufer G . Cardiac Surgery After Heart Transplantation: Elective Operation or Last Exit Strategy?. Transplant Direct. 2017; 3(10):e209. PMC: 5627740. DOI: 10.1097/TXD.0000000000000725. View

Hoffmeier A, Schmid C, Deng M, Weyand M, Kerber S, Schmidt C . Multiple cardiac procedures after heart transplantation: a case report. Thorac Cardiovasc Surg. 1996; 44(4):216-8. DOI: 10.1055/s-2007-1012021. View

10.

Holmes T, Jansz P, Spratt P, Macdonald P, Dhital K, Hayward C . Cardiac surgery is successful in heart transplant recipients. Heart Lung Circ. 2014; 23(8):703-10. DOI: 10.1016/j.hlc.2014.03.003. View

11.

Koyanagi T, Minami K, Tenderich G, Reiss N, Morshius M, Mirow N . Thoracic and cardiovascular interventions after orthotopic heart transplantation. Ann Thorac Surg. 1999; 67(5):1350-4. DOI: 10.1016/s0003-4975(99)00263-5. View

12.

Mohammadi S, Dagenais F, Senechal M, Leblanc M, Couture C, Voisine P . Degenerative mitral valve insufficiency long term after heart transplantation: clinical and surgical considerations. J Heart Valve Dis. 2007; 16(2):122-5. View

13.

Musci M, Yankah C, Klose H, Baretti R, Weng Y, Meyer R . Heart valve operations in solid organ recipients: an 18-year single-center experience. Transplantation. 2007; 84(5):592-7. DOI: 10.1097/01.tp.0000279005.85046.a6. View

14.

Rothenburger M, Hulsken G, Stypmann J, Wichter T, Tjan T, Loher A . Cardiothoracic surgery after heart and heart-lung transplantation. Thorac Cardiovasc Surg. 2005; 53(2):85-92. DOI: 10.1055/s-2004-830472. View

15.

Stahl R, Karwande S, Olsen S, Taylor D, Hawkins J, Renlund D . Tricuspid valve dysfunction in the transplanted heart. Ann Thorac Surg. 1995; 59(2):477-80. DOI: 10.1016/0003-4975(94)00860-a. View

16.

van der Merwe J, Casselman F, Stockman B, Vermeulen Y, Degrieck I, Van Praet F . Endoscopic Port Access Surgery for Late Orthotopic Cardiac Transplantation Atrioventricular Valve Disease. J Heart Valve Dis. 2017; 26(2):124-129. View

17.

Weston M, Vijayanagar R, Sastry N . Closure of a patent foramen ovale and tricuspid valve replacement after heart transplantation. Ann Thorac Surg. 1996; 61(2):717-9. DOI: 10.1016/0003-4975(95)00783-0. View

18.

Mohammed M, Rali A, Buechler T, Vuddanda V, Arshi J, Hosseini Dehkordi S . In-Hospital Outcomes and Trends of Tricuspid Valve Surgery in Heart Transplant Patients. Biomed Hub. 2020; 5(1):247-256. PMC: 7383286. DOI: 10.1159/000507179. View

19.

Kim H, Kim H, Lee S, Jung S, Yun T, Kim J . Prevalence and Risk Factors of Post-heart Transplant Tricuspid Regurgitation. Transplantation. 2022; 106(6):e297-e303. DOI: 10.1097/TP.0000000000004128. View

20.

Locali R, Matsuoka P, Cherbo T, Gabriel E, Buffolo E . [Should biatrial heart transplantation still be performed?: A Meta-analysis]. Arq Bras Cardiol. 2010; 94(6):829-40. DOI: 10.1590/s0066-782x2010000600018. View